Tracy Lane

Tracy Lane is head of development at Orbit Discovery, she is responsible for the development programmes for both affinity and functional screening. She has twenty years of research experience covering both academic and industrial settings. Prior to joining Orbit Discovery, her research focused on the role of a mutant G protein coupled receptor in schizophrenia and bipolar disorder. This research was based at the University of Oxford in collaboration with Eli Lilly and GlaxoSmithKline.

Previously, Tracy has researched factors involved in the migration, proliferation, and fate of neuronal stem cells based both at the University of Oxford and at Emory University (Atlanta G.A.). During her PhD at Sheffield University, she developed a novel biomaterial that was able to direct neuronal attachment and outgrowth.